In addition, some new imaging techniques have been used to predict IDH genotypes in gliomas, such as quantitative imaging of D-2-hydroxyglutarate [21] and MRI-based deep learning method [22]; these noninvasive highly accurate methods for the determination of IDH status can predict IDH status thereby facilitating clinical translation. Here, IDH1 is linked to central nervous system cancer.